Publications
Chosen filters:
Chosen filters:
Artificial intelligence and machine learning for medical imaging: A technology review KU Leuven
Artificial intelligence (AI) has recently become a very popular buzzword, as a consequence of disruptive technical advances and impressive experimental results, notably in the field of image analysis and processing. In medicine, specialties where images are central, like radiology, pathology or oncology, have seized the opportunity and considerable efforts in research and development have been deployed to transfer the potential of AI to clinical ...
Design and integration technology for miniature medical microsystems KU Leuven Ghent University
The electronic subsystem of wearable and implantable devices is constructed using board-level and package-level integration technology and this limits the achievable miniaturization. We will show that this limitation can be overcome by emerging wafer-level integration methods such as chip-in-wire technology. These technologies can even achieve mechanically bendable and stretchable subsystems.
Design and Integration Technology for Miniature Medical Microsystems Ghent University
The electronic subsystem of wearable and implantable devices is constructed using board-level and package-level integration technology and this limits the achievable miniaturization. We will show that this limitation can be overcome by emerging wafer-level integration methods such as chip-in-wire technology. These technologies can even achieve mechanically bendable and stretchable subsystems.
Egg banking in anticipation of age-related fertility decline : using medical technology for better, not for worse Ghent University
Machines that go 'ping': medical technology and health expenditures in OECD countries: corrigendum Ghent University
Governing nanomedicine: Lessons from within, and for, the EU Medical Technology regulatory framework KU Leuven
Rising health spending, new medical technology and the Baumol effect University of Antwerp
Impact of health technology assessment and managed entry schemes on reimbursement decisions of centrally authorised medicinal products in Belgium Vrije Universiteit Brussel
Purpose: Centrally authorised medicinal products (CAMPs) in the European Union may offer added therapeutic value (ATV) but may be linked to high prices and limited efficiency. Health technology assessment (HTA) and managed entry schemes (MES) may facilitate the reimbursement decision by providing reliable estimates of the medicinal product’s value and costs and by controlling the remaining uncertainty, respectively. We investigated the impact ...